Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1995 Sep 30;311(7009):857–859. doi: 10.1136/bmj.311.7009.857

Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice.

S P Fisher-Hoch 1, O Tomori 1, A Nasidi 1, G I Perez-Oronoz 1, Y Fakile 1, L Hutwagner 1, J B McCormick 1
PMCID: PMC2550858  PMID: 7580496

Abstract

OBJECTIVE--To investigate two hospital outbreaks of Lassa fever in southern central Nigeria. SETTING--Hospitals and clinics in urban and rural areas of Imo State, Nigeria. DESIGN--Medical records were reviewed in hospitals and clinics in both areas. Patients with presumed and laboratory confirmed Lassa fever were identified and contracts traced. Hospital staff, patients, and local residents were questioned, records were carefully reviewed, and serum samples were taken. Serum samples were assayed for antibody specific to Lassa virus, and isolates of Lassa virus were obtained. RESULTS--Among 34 patients with Lassa fever, including 20 patients, six nurses, two surgeons, one physician, and the son of a patient, there were 22 deaths (65% fatality rate). Eleven cases were laboratory confirmed, five by isolation of virus. Most patients had been exposed in hospitals (attack rate in patients in one hospital 55%). Both outbreak hospitals were inadequately equipped and staffed, with poor medical practice. Compelling, indirect evidence revealed that parenteral drug rounds with sharing of syringes, conducted by minimally educated and supervised staff, fuelled the epidemic among patients. Staff were subsequently infected during emergency surgery and while caring for nosocomially infected patients. CONCLUSION--This outbreak illustrates the high price exacted by the practice of modern medicine, particularly use of parenteral injections and surgery, without due attention to good medical practice. High priority must be given to education of medical staff in developing countries and to guidelines for safe operation of clinics and hospitals. Failure to do so will have far reaching, costly, and ultimately devastating consequences.

Full text

PDF
857

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alter M. J. Inapparent transmission of hepatitis C: footprints in the sand. Hepatology. 1991 Aug;14(2):389–391. [PubMed] [Google Scholar]
  2. Bowen G. S., Tomori O., Wulff H., Casals J., Noonan A., Downs W. G. Lassa fever in Onitsha, East Central State, Nigeria in 1974. Bull World Health Organ. 1975;52(4-6):599–604. [PMC free article] [PubMed] [Google Scholar]
  3. Carey D. E., Kemp G. E., White H. A., Pinneo L., Addy R. F., Fom A. L., Stroh G., Casals J., Henderson B. E. Lassa fever. Epidemiological aspects of the 1970 epidemic, Jos, Nigeria. Trans R Soc Trop Med Hyg. 1972;66(3):402–408. doi: 10.1016/0035-9203(72)90271-4. [DOI] [PubMed] [Google Scholar]
  4. Fabiyi A., Tomori O., Pinneo P. Lassa fever antibodies in hospital personnel in the Plateau State of Nigeria. Niger Med J. 1979 Jan;9(1):23–25. [PubMed] [Google Scholar]
  5. Frame J. D., Baldwin J. M., Jr, Gocke D. J., Troup J. M. Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings. Am J Trop Med Hyg. 1970 Jul;19(4):670–676. doi: 10.4269/ajtmh.1970.19.670. [DOI] [PubMed] [Google Scholar]
  6. Hersh B. S., Popovici F., Apetrei R. C., Zolotusca L., Beldescu N., Calomfirescu A., Jezek Z., Oxtoby M. J., Gromyko A., Heymann D. L. Acquired immunodeficiency syndrome in Romania. Lancet. 1991 Sep 14;338(8768):645–649. doi: 10.1016/0140-6736(91)91230-r. [DOI] [PubMed] [Google Scholar]
  7. Johnson K. M., McCormick J. B., Webb P. A., Smith E. S., Elliott L. H., King I. J. Clinical virology of Lassa fever in hospitalized patients. J Infect Dis. 1987 Mar;155(3):456–464. doi: 10.1093/infdis/155.3.456. [DOI] [PubMed] [Google Scholar]
  8. McCormick J. B., King I. J., Webb P. A., Johnson K. M., O'Sullivan R., Smith E. S., Trippel S., Tong T. C. A case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis. 1987 Mar;155(3):445–455. doi: 10.1093/infdis/155.3.445. [DOI] [PubMed] [Google Scholar]
  9. McCormick J. B., Webb P. A., Krebs J. W., Johnson K. M., Smith E. S. A prospective study of the epidemiology and ecology of Lassa fever. J Infect Dis. 1987 Mar;155(3):437–444. doi: 10.1093/infdis/155.3.437. [DOI] [PubMed] [Google Scholar]
  10. Tomori O., Fabiyi A., Sorungbe A., Smith A., McCormick J. B. Viral hemorrhagic fever antibodies in Nigerian populations. Am J Trop Med Hyg. 1988 Mar;38(2):407–410. doi: 10.4269/ajtmh.1988.38.407. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES